Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
not yet FDA-approved as of 2024
Research Use Only Important Compliance Notice This product is supplied exclusively for scientific, laboratory, and research purposes
To view or add a comment, sign in BREAKING: An FDA advisory committee voted to approve the peptide BPC-157 to be recommended for inclusion on the official compounding list
It also i nteracts with multiple biologi cal pathways, providing cytoprotective, neuroprotective, and anti-inflammatory effects
In doing so it protects your body from free radicals that cause oxidative stress
It is most often studied in combination with semaglutide (a GLP-1 receptor agonist) in a fixed-dose combination known as CagriSema, investigated in the REDEFINE trial programme
